ARVO Foundation Announces 2020 Bert M. Glaser, MD Award Recipient
Distinguished award presented to early-career retina investigator
Rockville, Md. — The Association for Research in Vision and Ophthalmology (ARVO) today announced Daniel SW Ting, MD, PhD, has received the Bert M. Glaser, MD Award for Innovative Research in Retina, which recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition. Ting is recognized with this award for research related to the development of a deep learning system to detect three major blinding retinal conditions including diabetic retinopathy, glaucoma and age-related macular degeneration. Ting is a consultant vitreo-retinal specialist at the Singapore National Eye Center, assistant professor of ophthalmology at Duke-NUS Medical School Singapore and a professor at the AI and Data Science Center in Zhongshan Ophthalmic Eye Center.
“This award recognizes Dr. Ting’s remarkable accomplishments as an innovator, clinician-scientist and leader in the field of artificial intelligence and its application in ophthalmology,” said ARVO Foundation Board of Governors Chair Paul Sternberg, Jr., MD, FARVO. “Dr. Ting exemplifies the young, innovative talent that Dr. Glaser appreciated and fostered through his own work.”
Ting is the 2017-2018 US-ASEAN J. W. Fulbright Scholar to Johns Hopkins University and the founding member of the AAO AI taskforce. He serves on several editorial boards, including Ophthalmology, Ophthalmology Retina and British of Journal of Ophthalmology. He has published 30 AI articles in JAMA, and more than 140 articles in journals such as Nature Medicine, Nature Digital Medicine, Nature Biomedical Engineering, Lancet Digital Health, Progress in Retinal and Eye Research and Ophthalmology. He has won several awards, including the 2019 USA Macula Society Evangelos Gragoudas Award, the 2018 APAO Young Ophthalmologist’s Award, the 2017 APTOS Young Innovator Award and presented with the FRCOphth McCartney Prize.
“I am extremely thankful and honored to be receiving this award, named after Dr. Bert M. Glaser,” said Ting. “Dr. Glaser was a great innovator, retinal surgeon, and, more importantly, a great teacher. In recent years, artificial intelligence (AI), deep learning in particular, has sparked tremendous interest in the technical and medical fields. The research direction of my lab will be mainly focused on clinical translation, medical ethics and safety regulation. Inspired by Dr. Glaser, I hope to be able to share my AI experience widely with the ophthalmology community, ranging from medical students to senior professionals.”
The $10,000 award, funded by the Glaser family through the ARVO Foundation, is named in memory of Bert M. Glaser, MD, a long-time retina researcher, surgeon, innovator and teacher whose life was cut short in 2017 after a brief illness. Award recipients must demonstrate that their work has led to the development of a new drug or technique that will revolutionize retina care. Read more about Bert M. Glaser.
Applications for the 2021 award open July 1 - Sept. 1, 2020. For more information about the Bert M. Glaser, MD Award for Innovative Research in Retina, visit ARVO’s website.
About ARVO: The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include 12,000 eye and vision researchers from more than 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. Learn more at ARVO.org.
About the ARVO Foundation: Established in 2001, the ARVO Foundation for Eye Research raises funds through partnerships, grants and sponsorships to support ARVO’s world-class education and career development resources for eye and vision researchers of all stages of career and education. Learn more at ARVOFoundation.org.